|
Workshop
[In-Person] Therapeutic Antibody Discovery and Development: Hit Generation, Engineering, Characterization, CMC and IND Enabling studies
Speakers:
Joshua Park (Loxo at Lilly), Srinivasa Bandi (Nutcracker Therapeutics), Alex Yang (Vir Biotechnology), Wendy Chen (Amgen), Lilia Koriazova (Erasca), Chris Frantz (Seagen), Yue Liu (Ab Studio)
Organizers:
Wenfeng Xu, PhD (Chantibody) and Joshua Park, PhD (Loxo at Lilly)
Date:
2024-02-06
Time:
8:40-17:00 Pacific Time
Registration fee:
Regular attendees: $295; Academic/Students/Postdocs: $95; Out-of-Pocket: $45; Major Sponsorship: $3000; Vendor Show: $695, Happy Hour Sponsorship: $975; Lunch Sponsorship: $1250; On-site Registration: $500
Location:
Crowne Plaza, Foster City, CA (San Francisco Bay Area)
Major Sponsor:
Vendor show vendors registered to date:
(18)Altruist Biologics; Alturas Analytics; Aton Biotech; ATUM; BioTether Sciences; Correlia Biosystems Inc; Curia; Ellegaard BioResearch; Emery Pharma; IDEXX BioAnalytics; ITR Laboratories; JOINN Biologics Us Inc.; Meadowhawk Biolabs; Mycenax; OmniAb; Pace Life Sciences; Protein Metrics; Waters
Registration: http://www.PBSS.org
Registration deadline:2024-02-03
(it will close sooner if the seating cap is reached)
About the Topic
Sponsored by Abzena, WuXi Biologics, Mycenax, Alturas Analytics
Agenda:
| Time (PST) |
Topic |
Presenter |
| 8:45-9:00 am |
PBSS Welcome and Introduction |
Shichang Miao, PBSS |
| 9:00-9:30 am |
Overview of Therapeutic Antibodies |
Joshua Park, PhD, Executive Director, Antibody Discovery, Loxo Oncology at Lilly |
| 9:30-10:30 am |
Antibody Discovery |
Joshua Park, PhD, Executive Director, Antibody Discovery, Loxo Oncology at Lilly |
| 10:30-10:40 am |
Major Sponsor Presentation |
Abzena |
| 10:40-11:00 am |
Break and Vendor Show |
- |
| 11:00am-12:00 pm |
Antibody Engineering |
Srinivasa Bandi, Associate Director, Nutcracker Therapeutics |
| 12:00-12:50 pm |
Lunch |
Sponsored by Mycenax |
| 12:50-1:50 pm |
In Vitro Assays and Characterization for Antibody Discovery and Development |
Alex Yang, PhD, Senior Scientist, Vir Biotechnology |
| 1:50-2:50 pm |
In Vivo Models for Antibody Discovery and Clinical Efficacy |
Wendy Chen, PhD, Scientist, Amgen |
| 2:50-3:00 pm |
Major Sponsor Presentation |
WuXi Biologics |
| 3:00-3:20 pm |
Break and Vendor Show |
- |
| 3:20-4:05 pm |
Cell Line Development and CMC |
Lilia Koriazova, PhD, Sr. Director, Biologics Pharmaceutical Sciences, Erasca |
| 4:05-4:35 pm |
IND Enabling Tox Studies |
Chris Frantz, PhD, Director, Toxicology, Seagen |
| 4:35-5:10 pm |
AI for Antibody Discovery |
Yue Liu, PhD, Founder and CEO, Ab Studio Inc. |
| 5:10-5:40 pm |
Panel Discussion |
All speakers |
| 5:40-6:40 pm |
Happy Hour |
Sponsored by Alturas Analytics |
2024-09-20, [In-Person] Nonclinical Safety Assessments of Biologics and Other Novel Modalities for IND/NDA/BLA Filings
|
2024-09-25, [Free Online] Development of Protein Degraders: Computational Modeling, Medicinal Chemistry and Early Development
|
2024-10-10, [In-Person] Regulatory Global Submission: Strategies and Best Practices for FDA, EMA and PMDA
|
2024-10-25, [Free Online Workshop] Unleashing the Power of Real-World Evidence / Data (RWE/RWD) to Facilitate Drug Discovery, Development, and Beyond
|
2024-11-01, [In-Person] Clinical Pharmacology Studies on Hepatic and Renal Impairments for NDA Filing: Strategies, Design, Conduct, Analysis and Regulatory Aspects
|
2024-11-13, [Free Online Workshop] Career Transition for Research Scientists: Business Development & BioPartnering
|
2024-11-15, [In-Person] Current State of Bioanalysis for Biologics and Cell/Gene Therapy Products: Refining Established Approaches for New Complex Therapies
|
2024-12-05, [Free Online] Innovative Mass Spectrometry and Related Technologies for Life Science and Drug Development
|
2024-12-13, Why All These New Modalities?
|
2025-01-22, [In-Person] Small-Molecule Formulation for Discovery & Early Development (jointly by PBSS / AAPS-BADG / Syner-G)
|
2025-02-06, [In-Person] Intellectual Property (IP) Strategies and Best Practices
|
|
Ads (in random order)
Submit a Text Ad
($250 for 2 months)
Allucent
Bringing innovation to Biotech w/ClinPharm Modeling & Simulation services to inform dose, design, modeling + development strategies.
|
PharmaResources
Top-tier small molecule CRO/CDMO offering comprehensive supports from Medicinal Chemistry, DMPK, and CMC to GMP manufacturing for commercialization.
|
Alturas Analytics, Inc.
Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
|
Simulations Plus
GastroPlus X: Science, models & refined algorithms—now with intuitive interface, faster processing & streamlined workflows for faster PBPK modeling.
|
Submit a Text Ad
|